ISPE’s Post

Manufacturing And Supply Chain: Making Space Between A Rock And A Hard Place In this article, Ben Comer, Chief Editor at Life Science Leader, looks towards next year and discusses manufacturing and supply chain processes with 7 executives in biopharma... Read below to find out what they had to say ⤵ #CDMO #Biopharma #Manufacturing

Manufacturing And Supply Chain: Making Space Between A Rock And A Hard Place In this article, Ben Comer, Chief Editor at Life Science Leader, looks towards next year and discusses manufacturing and supply chain processes with 7 executives in biopharma... Read below to find out what they had to say ⤵ #CDMO #Biopharma #Manufacturing

Manufacturing And Supply Chain: Making Space Between A Rock And A Hard Place In this article, Ben Comer, Chief Editor at Life Science Leader, looks towards next year and discusses manufacturing and supply chain processes with 7 executives in biopharma... Read below to find out what they had to say ⤵ #CDMO #Biopharma #Manufacturing

Driven by a commitment to Operational Excellence, Mankind Pharma charts a path to sustained success. Embracing continuous change, the organization optimizes internal processes, fostering innovation and setting new industry standards. #MankindPharma #Mankind #Pharma #MankindLeader #Operations #LeadershipInAction #OperationalExcellence

“Digital transformation” is now a reality across various industries, including life sciences, especially during COVID-19. Areas such as manufacturing, clinical trials, and supply chains are all primed for digital transformation. The various life science challenges hindering the digital transformation are: 1)Operational Cost. 2) Research and development. 3) Shortage of skills. 4) Clinical trials. 5) Supply chain disruptions. The life sciences sector continues to change at “breakneck” speed in 2024 and beyond. Companies need a mix of capabilities like business agility, collaboration, and decision-making to drive through the challenges. Visit our website to have more profound knowledge about the challenges: https://lnkd.in/dXsVwq4T #DigitalTransformation #LifeSciences #HealthcareInnovation #IndustryChallenges #Pharmaceuticals

In my recent article with Pharma Manufacturing, I discuss the exciting strides the pharma industry is making as leaders work to overcome #SupplyChain challenges, which a recent ASHP survey indicates are responsible for 37% of shortages. The key to a resilient and mature future for manufacturing is adopting an outcomes-based approach to #DigitalTransformation, guided by thorough research, assessment, and planning. Only then can you move on to implementation and evaluation. Be sure to check out the full piece and share your thoughts: https://lnkd.in/ggWrKbsp

I'm pleased to post the first report in a new series tracking #pharma R&D and investment decisions. We examine management decision-making for the first half of 2023 by 18 companies likely to have a drug selected for Medicare negotiation in the first years of the program. Here's what we found: Most company decisions in the first half of 2023 were more likely attributable to ongoing macroeconomic and company-specific trends than as a direct result of the #inflationreductionact. The same holds true for planned R&D spending and pipeline discontinuations. Despite industry claims that the #IRA will have a negative impact to manufacturers, management discussions made it clear that the U.S. market remains a priority market. Download the report here, and stay tuned for more in the series.

It was an absolute pleasure to be interviewed by European Pharmaceutical Manufacturer about all things LogiPharma, and the recent industry sustainability report we published. You can catch the interview here https://lnkd.in/e5abGaFY And the report is here https://lnkd.in/eTt72xKg Sustainability is right at the top of the bill as one of the key themes for LogiPharma '24. This year's 24th edition will be taking place 16-18 April in Lyon, France, and bringing together 2000+ E2E life sciences supply chain leaders to discuss the future of the industry. If you haven't got your pass yet, there's still time - head to https://lnkd.in/db7NKFy to check out the agenda and book your pass today! See you there 🙌 #pharma #meddevice #supplychain #logipharma #sustainability #lifesciences #transformation

💡PHARMA and companies impacted by the industries cuts in R&D are grappling with the ‘reasons’ 💡The Patent Cliff- this has been known and discussed for many years. 💡The inflation Reduction act. This WSJ article shines a lens on Charles River and how Pharma decisions are deeply impacting their business? Are they right? OR is a deeper problem and these two are just easier to point at? Feel free to add your thoughts below.